UNTERNEHMENSDATEN
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company mainta …
KURSVERLAUF
1T
-1,6 %
1W
-6,9 %
1M
-6,7 %
6M
+140 %
YTD
+213,4 %
1J
+333,5 %
2J
+346,4 %
5J
-7,7 %
10J
–
FRAG DIE AGENTEN ZU DFTX
Keine Anlageberatung. Für die vollständige Analyse-Übersicht: zur Analyse-Seite →
ANALYSTEN-EINSCHÄTZUNG
KURSZIEL TIEF
25,00 $
KONSENS
51,30 $
MEDIAN
55,00 $
KURSZIEL HOCH
73,00 $
0
STRONG BUY
10
BUY
0
HOLD
0
SELL
0
STRONG SELL
10
GESAMT · Buy
| DATUM | ANALYSTENHAUS | RATING | AKTION |
|---|---|---|---|
| 24.07.2026 | Piper Sandler | Overweight | maintain |
| 08.07.2026 | Stifel | Buy | maintain |
| 30.06.2026 | Canaccord Genuity | Buy | maintain |
| 24.06.2026 | Jones Trading | Buy | maintain |
| 23.06.2026 | Needham | Buy | maintain |
| 23.06.2026 | Baird | Outperform | maintain |
| 22.06.2026 | Oppenheimer | Outperform | maintain |
| 22.06.2026 | Leerink Partners | Outperform | maintain |
KENNZAHLEN
KGV
-16,78
KBV
16,37
EV/EBITDA
-19,4
EIGENKAPITALRENDITE
-27,6 %
NETTOMARGE
0 %
VERSCHULDUNG (D/E)
0
DIVIDENDENRENDITE
0 %
STAND
31.03.2026
FREE FLOAT & LIQUIDITÄT
STREUBESITZ
98,3 %
AKTIEN IM STREUBESITZ
107.199.560
Ø TAGESVOLUMEN (30T)
3.708.442
INVESTIERTE FONDS
| FONDS / INSTITUTION | ANTEILE | VERÄNDERUNG | STAND |
|---|---|---|---|
| PEAK FINANCIAL ADVISORS LLC | 56.915 | +56.915 | 30.06.2026 |
| Y-Intercept (Hong Kong) Ltd | 54.466 | +54.466 | 30.06.2026 |
| MOODY ALDRICH PARTNERS LLC | 51.025 | +51.025 | 30.06.2026 |
| Police & Firemen's Retirement System of New Jersey | 38.386 | +11.025 | 30.06.2026 |
| TD Waterhouse Canada Inc. | 36.694 | +34.892 | 30.06.2026 |
AKTIENSPLITS
| DATUM | VERHÄLTNIS |
|---|---|
| 29.08.2022 | 1:15 |
| 03.03.2020 | 1:8 |
Keine Anlageberatung. Vergangene Wertentwicklung ist kein Indikator für zukünftige Ergebnisse.